Chimerix Inc.
This article was originally published in Start Up
Executive Summary
Chimerix Inc. is making headway on an oral drug that can be used to treat individuals exposed to the smallpox virus and to treat side effects of the smallpox vaccination. This, as well as the company's future products, will be delivered via a proprietary platform that uses the body's fat transport system to get nucleotides and other drugs into cells.